ArticlePloS one2026
Repetitive hypoxic preconditioning protects retinal ganglion cells against damage caused by exposure to blast.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Visual system damage and dysfunction caused by exposure to a blast wave has been described in both clinical studies and in pre-clinical models. Within the retina, retinal ganglion cells (RGC) exhibit sensitivity to mild blast-mediated traumatic brain injury (bTBI), which can result in progressive neurodegeneration. The purpose of this study was to determine if repetitive hypoxic preconditioning (HPC) can prevent bTBI-mediated RGC damage and death. This study utilized clinically relevant outcomes of RGC structure and function, supported by histological analysis of the surviving RGCs. Mice were exposed to six sessions of HPC over a two-week period at an 11% oxygen concentration, and subsequently subjected to bTBI using a shock tube. Four-weeks following exposure to bTBI or sham, functional and structural analysis of RGCs was performed using the pattern electroretinogram (PERG) and optical coherence tomography (OCT). BRN3A antibody labeling was subsequently used to quantify the number of RGCs surviving at the termination of the study. Analysis of RGC outcomes showed significantly decreased PERG amplitude and RGC Complex + retinal nerve fiber layer (RNFL) thickness in mice with bTBI compared to sham. There was no significant difference in RGC outcomes between sham mice and HPC+ bTBI mice. Taken together, these results show that HPC can provide at least partial neuroprotection to RGCs prior to blast exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.